博文

APASL2023 Interview | Professor Tim Greten: Research status, application and challenges of biomarkers related to immunotherapy of liver cancer

日期：
0

Professor Masatoshi Kudo：Novel Treatment Strategy in Intermediate-Stage HCC

日期：
0

Professor Scott L. Friedman: The dawn is ahead——Evolving Challenges in Hepatic Fibrosis

日期：
0

Professor Luca Valenti: Molecular genetic characteristics and clinical application of metabolic fatty liver disease (MAFLD)

日期：
0

Is Immunotherapy Feasible in Chronic Acute Liver Failure?

日期：
0

NAFLD Related Liver Cancer Risk Screening and Intervention

日期：
0

Risk Stratification and Treatment Options of Medium-Term HCC

日期：
0

Targeting cccDNA - the Clinical Cure of Chronic Hepatitis B

日期：
0